SCHEMBL7102424

SCHEMBL7102424

CCc1cc2c(Cl)nc(CCCCC(=O)O)nc2s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 4/20 0.47
HSD17B10 Q99714 1/20 0.47
SELE P16581 1/20 0.44
VCAM1 P19320 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.40
RAB9A P51151 1/20 0.40
P2RY12 Q9H244 3/20 0.39
TMIGD3 P0DMS9 1/20 0.38
ADORA1 P30542 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
POLB P06746 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7096431 0.99 KDM4E (0.46) ALDH1A1KDM4EHSD17B10SELEVCAM1
SCHEMBL7098332 0.91 ALDH1A1 (0.50) ALDH1A1KDM4EHSD17B10SELEVCAM1
SCHEMBL6708399 0.87 SELE (0.41) ALDH1A1KDM4EHSD17B10SELEVCAM1
SCHEMBL7101086 0.85 CSNK2A2 (0.43) ALDH1A1KDM4EHSD17B10MEN1KMT2A
SCHEMBL7101124 0.84 F13A1 (0.39) ALDH1A1TDP1POLBLMNAPRNP
SCHEMBL6706662 0.83 SELE (0.42) ALDH1A1KDM4EHSD17B10SELEVCAM1
SCHEMBL6706646 0.81 SELE (0.44) ALDH1A1KDM4EHSD17B10SELEVCAM1
SCHEMBL31044813 0.78 SELE (0.58) ALDH1A1KDM4EHSD17B10SELEVCAM1
SCHEMBL7100819 0.76 CSNK2A2 (0.46) ALDH1A1KDM4EHSD17B10MEN1KMT2A
SCHEMBL6708361 0.72 HPGD (0.38) ALDH1A1KDM4EKMT2AP2RY12L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1355649-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO 4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GmbH (DE) 2003-10-29 EP disclosed
EP-1347761-A2 PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GmbH (DE) 2003-10-01 EP disclosed
EP-1337256-A2 USE OF THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2003-08-27 EP disclosed
WO-2002060449-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO[4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GMBH (DE) 2002-08-08 WO disclosed
WO-2002049650-A2 PHARMACEUTICAL FORMULATION CONTAINING THIENOPYRIMIDINES AND ANTITHROMBOTICS, CALCIUM ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GMBH (DE) 2002-06-27 WO disclosed
WO-2002041896-A2 USE OF THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 2002-05-30 WO disclosed
EP-1036078-A1 THIENOPYRIMIDINES MERCK PATENT GmbH (DE) 2000-09-20 EP disclosed
WO-1999028325-A1 THIENOPYRIMIDINES MERCK PATENT GMBH (DE) 1999-06-10 WO disclosed